Acute kidney injury predicts mortality in very elderly critically-ill patients
Alba Schmidt E, De Rosa S, Müller J, Hüsing P, Daniels R, Theile P, Schweingruber N, Kluge S, Huber T, Roedl K, Schmidt-Lauber C
EUR J INTERN MED. 2024;127:119-125.

Auswirkungen von COVID-19 in der Gefäßmedizin: erhöhtes Thromboserisiko und Hinweise für Kollateralschäden
Besch A, Roedl K, Behrendt C
Päd Praxis. 2024;2024(101):345-356.

Clinical Presentation and Outcome of Critically Ill Patients with Inflammatory Bowel Disease
Böttcher M, Bertram F, Sabihi M, Lücke J, Ahmadi P, Kluge S, Roedl K, Huber S, Wichmann D, Manthey C
VISC MED. 2024;40(2):75-81.

Evolution of Clinical Characteristics and Outcomes of Critically Ill Patients 90 Years Old or Older Over a 12-Year Period: A Retrospective Cohort Study
Daniels R, Müller J, Jafari C, Theile P, Kluge S, Roedl K
CRIT CARE MED. 2024;52(6):e258-e267.

Continuous Renal Replacement Therapy During Extracorporeal Membrane Oxygenation
De Rosa S, Roedl K, Balzani E, Bellani G, Ostermann M
2024. Nutrition, Metabolism and Kidney Support: A Critical Care Approach. Cotoia A, De Rosa S, Ferrari F, Pota V, Umbrello M (eds.). 1. ed. Cham: Springer, Cham, 625-638.

Intensive care unit cardiac arrest among very elderly critically ill patients - is cardiopulmonary resuscitation justified?
Haar M, Müller J, Hartwig D, von Bargen J, Daniels R, Theile P, Kluge S, Roedl K
SCAND J TRAUMA RESUS. 2024;32(1):84.

Outcomes in very elderly ICU patients surgically treated for proximal femur fractures
Heuer A, Müller J, Strahl A, Fensky F, Daniels R, Theile P, Frosch K, Kluge S, Hubert J, Thiesen D, Roedl K
SCI REP-UK. 2024;14(1):1376.

Lebererkrankungen auf der Intensivstation
Roedl K, Fuhrmann V
MED KLIN-INTENSIVMED. 2024;119(6):449-457.

Wie lange soll man innerklinisch reanimieren
Roedl K, Kluge S
Intensiv News. 2024;28(3):16-18.

Glucocorticoids induce a maladaptive epithelial stress response to aggravate acute kidney injury
Zhou L, Pereiro M, Li Y, Derigs M, Kuenne C, Hielscher T, Huang W, Kränzlin B, Tian G, Kobayashi K, Lu G, Roedl K, Schmidt C, Günther S, Looso M, Huber J, Xu Y, Wiech T, Sperhake J, Wichmann D, Gröne H, Worzfeld T
SCI TRANSL MED. 2024;16(767):eadk5005.

Incidence of Hypoxic Hepatitis in Patients with Cardiogenic Shock and Association with Mortality
Beer B, Besch L, Weimann J, Surendra K, Roedl K, Grensemann J, Sundermeyer J, Dettling A, Kluge S, Kirchhof P, Blankenberg S, Scherer C, Schrage B
EUR HEART J-ACUTE CA. 2023;12(10):663-670.

Auswirkungen von COVID-19 in der Gefäßmedizin: erhöhtes Thromboserisiko und Hinweise für Kollateralschäden
Besch A, Roedl K, Behrendt C
Internistische Praxis. 2023;67(2):278-289.

Comparative analysis of characteristics and outcomes in hospitalized COVID-19 patients infected with different SARS-CoV-2 variants between January 2020 and April 2022 - A retrospective single-center cohort study
Brehm T, Heyer A, Woo M, Fischer M, van der Meirschen M, Wichmann D, Jarczak D, Roedl K, Schmiedel S, Addo M, Lütgehetmann M, Christner M, Huber S, Lohse A, Kluge S, Schulze Zur Wiesch J
J INFECT PUBLIC HEAL. 2023;16(11):1806-1812.

Clinical characteristics, causes and predictors of outcomes in patients with in-hospital cardiac arrest: results from the SURVIVE-ARREST study
Hannen L, Toprak B, Weimann J, Mahmoodi B, Fluschnik N, Schrage B, Roedl K, Söffker G, Kluge S, Issleib M, Blankenberg S, Kirchhof P, Clemmensen P, Sinning C, Zengin-Sahm E, Becher P
CLIN RES CARDIOL. 2023;112(2):258-269.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Higgins A, Berry L, Lorenzi E, Murthy S, McQuilten Z, Mouncey P, Al-Beidh F, Annane D, Arabi Y, Beane A, van Bentum-Puijk W, Bhimani Z, Bonten M, Bradbury C, Brunkhorst F, Burrell A, Buzgau A, Buxton M, Charles W, Cove M, Detry M, Estcourt L, Fagbodun E, Fitzgerald M, Girard T, Goligher E, Goossens H, Haniffa R, Hills T, Horvat C, Huang D, Ichihara N, Lamontagne F, Marshall J, McAuley D, McGlothlin A, McGuinness S, McVerry B, Neal M, Nichol A, Parke R, Parker J, Parry-Billings K, Peters S, Reyes L, Rowan K, Saito H, Santos M, Saunders C, Serpa-Neto A, Seymour C, Shankar-Hari M, Stronach L, Turgeon A, Turner A, van de Veerdonk F, Zarychanski R, Green C, Lewis R, Angus D, McArthur C, Berry S, Derde L, Gordon A, Webb S, Lawler P
JAMA-J AM MED ASSOC. 2023;329(1):39-51.

Effect of Hemadsorption Therapy in Critically Ill Patients with COVID-19 (CYTOCOV-19): A Prospective Randomized Controlled Pilot Trial
Jarczak D, Roedl K, Fischer M, Heer G, Burdelski C, Frings D, Sensen B, Boenisch O, Tariparast A, Kluge S, Nierhaus A
BLOOD PURIFICAT. 2023;52(2):183-192.

Postreanimationsbehandlung – vom Erkennen des Spontankreislaufs zur Intensivmedizin
Metelmann C, Katzenschlager S, Roedl K, Seewald S, Wnent J
Notfallmedizin up2date. 2023;18(4):375-394.

SOP Postreanimationsbehandlung
Metelmann C, Katzenschlager S, Roedl K, Seewald S, Wnent J
Notfallmedizin up2date. 2023;18(4):361-366.

Residual risk identified in routine noninvasive follow-up assessments in pulmonary arterial hypertension
Ostermann J, Pott J, Hennigs J, Roedl K, Sinning C, Harbaum L, Klose H
ERJ OPEN RES. 2023;9(3):.

Impact of COVID-19 on Sedation Requirements during Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome
Paparoupa M, Fischer M, Pinnschmidt H, Grensemann J, Roedl K, Kluge S, Jarczak D
J CLIN MED. 2023;12(10):.

Occurrence, characteristics and outcome of hypoxic liver injury among patients aged ≥ 90 years admitted to the intensive care unit - a retrospective cohort study
Roedl K, Daniels R, Theile P, Fuhrmann V, Kluge S, Müller J
GERONTOLOGY. 2023;69(6):728-736.

The Independent Impact of Peripheral Arterial Disease on Mortality in Nonagenarians and Centenarians Who Were Treated in an Intensive Care Unit: A Consecutive Cohort of 1 108 Patients
Roedl K, Daniels R, Theile P, Kluge S, Müller J, Behrendt C
EUR J VASC ENDOVASC. 2023;65(4):582-589.

Early acute kidney injury and transition to renal replacement therapy in critically ill patients with SARS-CoV-2 requiring veno-venous extracorporeal membrane oxygenation
Roedl K, De Rosa S, Fischer M, Braunsteiner J, Schmidt-Lauber C, Jarczak D, Huber T, Kluge S, Wichmann D
ANN INTENSIVE CARE. 2023;13(1):115.

Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest
Roedl K, Kluge S
NEW ENGL J MED. 2023;388(3):285.

Temperaturmanagement nach Herz-Kreislauf-Stillstand – eine Umfrage zur klinischen Praxis in Deutschland
Roedl K, Kluge S
MED KLIN-INTENSIVMED. 2023;118(5):393-395.

Die HACA in-hospital Studie: Hypotherme oder Normotherme Temperaturkontrolle nach innerklinischem Herzkreislaufstillstand
Roedl K, Wolfrum S
Spitzenforschung in der Dermatologie - Innovationen und Auszeichunungen. 2023;2023:34-39.

Response by Roedl et al to Letter Regarding Article, "Temperature Control After In-Hospital Cardiac Arrest: A Randomized Clinical Trial"
Roedl K, Wolfrum S, Kluge S
CIRCULATION. 2023;147(24):1852-1853.

Vorgehen nach erfolgreicher Reanimation – kühlen oder nicht mehr kühlen?
Roedl K, Wolfrum S, Kluge S
INNERE MED. 2023;64(10):932-938.

Temperature control in adults after cardiac arrest: a survey of current clinical practice in Germany
Roedl K, Wolfrum S, Michels G, Pin M, Söffker G, Janssens U, Kluge S
CRIT CARE. 2023;27(1):.

Association between Red Cell Distribution Width and Outcomes of Nonagenarians Admitted to the Intensive Care Unit-A Retrospective Cohort Study
Theile P, Müller J, Daniels R, Kluge S, Roedl K
DIAGNOSTICS. 2023;13(20):.

Clinical surrogates of dysautonomia predict lethal outcome in COVID-19 on intensive care unit
Woo M, Mayer C, Fischer M, Kluge S, Roedl K, Gerloff C, Czorlich P, Thomalla G, Schulze Zur Wiesch J, Schweingruber N
NEUROL RES PRACT. 2023;5(1):17.

Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart
Bräuninger H, Stoffers B, Fitzek A, Meißner K, Aleshcheva G, Schweizer M, Weimann J, Rotter B, Warnke S, Edler C, Braun F, Roedl K, Scherschel K, Escher F, Kluge S, Huber T, Ondruschka B, Schultheiss H, Kirchhof P, Blankenberg S, Püschel K, Westermann D, Lindner D
CARDIOVASC RES. 2022;118(2):542-555.

Outcomes of critically ill coronavirus disease 2019 patients requiring kidney replacement therapy: A retrospective cohort study
Braunsteiner J, Kluge S, Schmidt-Lauber C, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Hoxha E, Huber T, Wichmann D, Kluge S, Fischer M, Roedl K
FRONT MED-LAUSANNE. 2022;9:.

New Insights in the Occurrence of Venous Thromboembolism in Critically Ill Patients with COVID-19 - A Large Postmortem and Clinical Analysis
Heinrich F, Roedl K, Jarczak D, Goebels H, Heinemann A, Schäfer U, Ludwig F, Bachmann M, Bein B, Weber C, Sydow K, Bota M, Paschen H, Weerth A, Veit C, Detsch O, Brand P, Kluge S, Ondruschka B, Wichmann D
VIRUSES-BASEL. 2022;14(4):.

Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation
Herrmann J, Lotz C, Karagiannidis C, Weber-Carstens S, Kluge S, Putensen C, Wehrfritz A, Schmidt K, Ellerkmann R, Oswald D, Lotz G, Zotzmann V, Moerer O, Kühn C, Kochanek M, Muellenbach R, Gaertner M, Fichtner F, Brettner F, Findeisen M, Heim M, Lahmer T, Rosenow F, Haake N, Lepper P, Rosenberger P, Braune S, Kohls M, Heuschmann P, Meybohm P
CRIT CARE. 2022;26(1):.

The Prevalence of Early‐ and Late‐Onset Bacterial, Viral and Fungal Respiratory Superinfections in Invasively Ventilated COVID‐19 Patients.
Paparoupa M, Aldemyati R, Roggenkamp H, Berinson B, Nörz D, Olearo F, Kluge S, Roedl K, Heer G, Wichmann D
J MED VIROL. 2022;94(5):1920-1925.

The effects of SARS-CoV-2 virus type and of vaccination status on causes of death over the course of the COVID-19 pandemic
Paparoupa M, Schröder A, Braunsteiner J, Addo M, Lütgehetmann M, Roedl K, Kluge S, Ondruschka B, Wichmann D
DTSCH ARZTEBL INT. 2022;119(35-36):607-608.

Chronic Critical Illness in Patients with COVID-19: Characteristics and Outcome of Prolonged Intensive Care Therapy
Roedl K, Jarczak D, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Kluge S, Wichmann D
J CLIN MED. 2022;11(4):.

Hypothermie oder Normothermie nach innerklinischem Herzkreislaufstillstand: Ist hier wieder alles anders?
Roedl K, Kluge S
Intensiv News. 2022;26(6):7-10.

Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors
Voigtlaender M, Edler C, Gerling M, Schädler J, Ondruschka B, Schröder A, Sperhake J, Ehrhardt S, Wang L, Haddad M, Kiencke V, Renné T, Roedl K, Kluge S, Wichmann D, Langer F
THROMB RES. 2022;218:171-176.

Molecular consequences of SARS-CoV-2 liver tropism
Wanner N, Andrieux G, Badia-I-Mompel P, Edler C, Pfefferle S, Lindenmeyer M, Schmidt-Lauber C, Czogalla J, Wong M, Okabayashi Y, Braun F, Lütgehetmann M, Meister E, Lu S, Noriega M, Günther T, Grundhoff A, Fischer N, Bräuninger H, Lindner D, Westermann D, Haas F, Roedl K, Kluge S, Addo M, Huber S, Lohse A, Reiser J, Ondruschka B, Sperhake J, Saez-Rodriguez J, Boerries M, Hayek S, Aepfelbacher M, Scaturro P, Puelles V, Huber T
NAT METAB. 2022;4(3):310-319.

Temperature Control After In-Hospital Cardiac Arrest: A Randomized Clinical Trial
Wolfrum S, Roedl K, Hanebutte A, Pfeifer R, Kurowski V, Riessen R, Daubmann A, Braune S, Söffker G, Bibiza-Freiwald E, Wegscheider K, Schunkert H, Thiele H, Kluge S
CIRCULATION. 2022;146(18):1357-1366.

Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020
Brehm T, Heyer A, Roedl K, Jarczak D, Nierhaus A, Nentwich M, van der Meirschen M, Schultze A, Christner M, Fiedler W, Kröger N, Huber T, Klose H, Sterneck M, Jordan S, Kreuels B, Schmiedel S, Addo M, Huber S, Lohse A, Kluge S, Schulze Zur Wiesch J
J CLIN MED. 2021;10(11):.

Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza
Brehm T, van der Meirschen M, Hennigs A, Roedl K, Jarczak D, Wichmann D, Frings D, Nierhaus A, Oqueka T, Fiedler W, Christopeit M, Kraef C, Schultze A, Lütgehetmann M, Addo M, Schmiedel S, Kluge S, Schulze Zur Wiesch J
SCI REP-UK. 2021;11(1):.

Voriconazole Pharmacokinetics Are Not Altered in Critically Ill Patients with Acute-on-Chronic Liver Failure and Continuous Renal Replacement Therapy: An Observational Study
Grensemann J, Pfaffendorf C, Wicha S, Koenig C, Roedl K, Jarczak D, Iwersen-Bergmann S, Manthey C, Kluge S, Fuhrmann V
MICROORGANISMS. 2021;9(10):2087.

SARS-CoV-2 Blood RNA Load Predicts Outcome in Critically Ill COVID-19 Patients
Heinrich F, Nentwich M, Bibiza-Freiwald E, Nörz D, Roedl K, Christner M, Hoffmann A, Olearo F, Kluge S, Aepfelbacher M, Wichmann D, Lütgehetmann M, Pfefferle S
OPEN FORUM INFECT DI. 2021;8(11):.

Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR
Olearo F, Nörz D, Heinrich F, Sutter J, Roedl K, Schultze A, Wiesch J, Braun P, Oestereich L, Kreuels B, Wichmann D, Aepfelbacher M, Pfefferle S, Lütgehetmann M
J CLIN VIROL. 2021;137:.

Association of COVID-19 with Intracranial Hemorrhage during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A 10-Year Retrospective Observational Study
Pantel T, Roedl K, Jarczak D, Yu Y, Frings D, Sensen B, Pinnschmidt H, Bernhardt A, Cheng B, Lettow I, Westphal M, Czorlich P, Kluge S, Fischer M
J CLIN MED. 2021;11(1):.

Herz-Kreislauf-Stillstand bei über 90-Jährigen – neurologisches Outcome und intensivmedizinische Therapie
Roedl K
MED KLIN-INTENSIVMED. 2021;116(6):535-536.

Letter to the Editor in regard to the "Effects of COVID-19 on in-hospital cardiac arrest
Roedl K
SCAND J TRAUMA RESUS. 2021;29(1):159.

Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19
Roedl K, Heidenreich S, Pfefferle S, Jarczak D, Urbanowicz T, Nörz D, Aepfelbacher M, Kröger N, Kluge S, Lütgehetmann M, Christopeit M, Wichmann D
AM J RESP CRIT CARE. 2021;203(2):242-245.

Severe liver dysfunction complicating course of COVID-19 in the critically ill: multifactorial cause or direct viral effect?
Roedl K, Jarczak D, Drolz A, Wichmann D, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Lütgehetmann M, Kluge S, Fuhrmann V
ANN INTENSIVE CARE. 2021;11(1):.

MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19
Roedl K, Jarczak D, Fischer M, Haddad M, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Karakas M, Kluge S, Nierhaus A
BIOMARKERS. 2021;26(5):417-424.

Mechanical ventilation and mortality among 223 critically ill patients with coronavirus disease 2019: A multicentric study in Germany
Roedl K, Jarczak D, Thasler L, Bachmann M, Schulte F, Bein B, Weber C, Schäfer U, Veit C, Hauber H, Kopp S, Sydow K, de Weerth A, Bota M, Schreiber R, Detsch O, Rogmann J, Frings D, Sensen B, Burdelski C, Boenisch O, Nierhaus A, de Heer G, Kluge S
AUST CRIT CARE. 2021;34(2):167-175.

Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation—A Retrospective Cohort Study
Roedl K, Kahn A, Jarczak D, Fischer M, Boenisch O, Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Braune S, Yildirim Y, Bernhardt A, Reichenspurner H, Kluge S, Wichmann D
J CLIN MED. 2021;10(22):.

Neue Erkenntnisse zur Ursache von Herzkreislaufstillständen im Krankenhaus
Roedl K, Kluge S
DEUT MED WOCHENSCHR. 2021;146(11):733-737.

Reanimation auf der Intensivstation (auch in Zeiten von COVID-19): Ist hier alles ganz anders?
Roedl K, Kluge S, Söffker G
Intensiv News. 2021;25(2):1-5.

Effects of COVID-19 on in-hospital cardiac arrest: incidence, causes, and outcome - a retrospective cohort study
Roedl K, Söffker G, Fischer D, Müller J, Westermann D, Issleib M, Kluge S, Jarczak D
SCAND J TRAUMA RESUS. 2021;29(1):30.

Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19—A Retrospective Study
Roedl K, Söffker G, Wichmann D, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Westermann D, Kluge S, Jarczak D
J CLIN MED. 2021;10(10):.

High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study
Schroeder M, Schaumburg B, Mueller Z, Parplys A, Jarczak D, Roedl K, Nierhaus A, Heer G, Grensemann J, Schneider B, Stoll F, Bai T, Jacobsen H, Zickler M, Stanelle-Bertram S, Klaetschke K, Renné T, Meinhardt A, Aberle J, Hiller J, Peine S, Kreienbrock L, Klingel K, Kluge S, Gabriel G
EMERG MICROBES INFEC. 2021;10(1):1807-1818.

Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19
Woo M, Haag F, Nierhaus A, Jarczak D, Roedl K, Mayer C, Brehm T, van der Meirschen M, Hennigs A, Christopeit M, Fiedler W, Karagiannis P, Burdelski C, Schultze A, Huber S, Addo M, Schmiedel S, Friese M, Kluge S, Schulze Zur Wiesch J
ISCIENCE. 2021;24(7):102752.

Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients
Zhao Y, Kilian C, Turner J, Bosurgi L, Roedl K, Bartsch P, Gnirck A, Cortesi F, Schultheiß C, Hellmig M, Enk L, Hausmann F, Borchers A, Wong M, Paust H, Siracusa F, Scheibel N, Herrmann M, Rosati E, Bacher P, Kylies D, Jarczak D, Lütgehetmann M, Pfefferle S, Steurer S, Zur Wiesch J, Puelles V, Sperhake J, Addo M, Lohse A, Binder M, Huber S, Huber T, Kluge S, Bonn S, Panzer U, Gagliani N, Krebs C
SCI IMMUNOL. 2021;6(56):.

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Angus D, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, van Bentum-Puijk W, Berry L, Bhimani Z, Bonten M, Bradbury C, Brunkhorst F, Buxton M, Buzgau A, Cheng A, de Jong M, Detry M, Estcourt L, Fitzgerald M, Goossens H, Green C, Haniffa R, Higgins A, Horvat C, Hullegie S, Kruger P, Lamontagne F, Lawler P, Linstrum K, Litton E, Lorenzi E, Marshall J, McAuley D, McGlothin A, McGuinness S, McVerry B, Montgomery S, Mouncey P, Murthy S, Nichol A, Parke R, Parker J, Rowan K, Sanil A, Santos M, Saunders C, Seymour C, Turner A, van de Veerdonk F, Venkatesh B, Zarychanski R, Berry S, Lewis R, McArthur C, Webb S, Gordon A
JAMA-J AM MED ASSOC. 2020;324(13):1317-1329.

Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure
Fuhrmann V, Weber T, Roedl K, Motaabbed J, Tariparast A, Jarczak D, de Garibay A, Kluwe J, Boenisch O, Herkner H, Kellum J, Kluge S
ANN INTENSIVE CARE. 2020;10(1):96.

Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
Ghandili S, Pfefferle S, Roedl K, Sonnemann P, Karagiannis P, Boenisch O, Kluge S, Schmiedel S, Ittrich H, Rohde H, Lütgehetmann M, Weisel K, Bokemeyer C, Wichmann D, Fiedler W, Jarczak D, Modemann F
BLOOD ADV. 2020;4(23):5936-5941.

Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study
Grensemann J, Busse D, König C, Roedl K, Jäger W, Jarczak D, Iwersen-Bergmann S, Manthey C, Kluge S, Kloft C, Fuhrmann V
ANN INTENSIVE CARE. 2020;10(1):48.

Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)
Karakas M, Jarczak D, Becker M, Roedl K, Addo M, Hein F, Bergmann A, Zimmermann J, Simon T, Marx G, Lütgehetmann M, Nierhaus A, Kluge S
BIOMOLECULES. 2020;10(8):.

Cardiac SARS-CoV-2 infection is associated with distinct transcriptomic changes within the heart
Lindner D, Bräuninger H, Stoffers B, Fitzek A, Meißner K, Aleshcheva G, Schweizer M, Weimann J, Rotter B, Warnke S, Edler C, Braun F, Roedl K, Scherschel K, Escher F, Kluge S, Huber T, Ondruschka B, Heinz-Peter-Schultheiss , Kirchhof P, Blankenberg S, Püschel K, Westermann D
medRxiv. 2020;2020.12.19.20248542.

Epidemiology of intensive care unit cardiac arrest: characteristics, comorbidities, and post-cardiac arrest organ failure - a prospective observational study
Roedl K, Jarczak D, Blohm R, Winterland S, Müller J, Fuhrmann V, Westermann D, Söffker G, Kluge S
RESUSCITATION. 2020;156:92-98.

Intensivmedizin und COVID-19
Roedl K, Kluge S, Wichmann D
Klinikarzt. 2020;2020(49):409-413.

Lactate Improves Prediction of Short-Term Mortality in Critically Ill Patients With Cirrhosis
Drolz A, Horvatits T, Rutter K, Landahl F, Roedl K, Meersseman P, Wilmer A, Kluwe J, Lohse A, Kluge S, Trauner M, Fuhrmann V
HEPATOLOGY. 2019;69(1):258-269.

The chronic ICU patient: Is intensive care worthwhile for patients with very prolonged ICU-stay (≥ 90 days)?
Roedl K, Amann D, Eichler L, Fuhrmann V, Kluge S, Müller J
EUR J INTERN MED. 2019;69:71-76.

Hypoxic liver injury after in- and out-of-hospital cardiac Arrest: Risk factors and neurological outcome.
Roedl K, Spiel A, Nürnberger A, Horvatits T, Drolz A, Hubner P, Warenits A, Sterz F, Herkner H, Fuhrmann V
RESUSCITATION. 2019;137:175-182.

Akutes Leberversagen: Zeitgerechte Diagnose und Therapie ist entscheidend für die Prognose
Rutter K, Horvatits T, Drolz A, Roedl K, Siedler S, Kluge S, Fuhrmann V
Wiener klinisches Magazin. 2019;22(1):38-47.

Neuron-specific-enolase as a predictor of the neurologic outcome after cardiopulmonary resuscitation in patients on ECMO
Schrage B, Rübsamen N, Becher P, Roedl K, Söffker G, Schwarzl M, Dreher A, Schewel J, Ghanem A, Grahn H, Lubos E, Bernhardt A, Kluge S, Reichenspurner H, Blankenberg S, Spangenberg T, Westermann D
RESUSCITATION. 2019;136(Marcz 2019):14-20.

Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease
Drolz A, Horvatits T, Roedl K, Rutter K, Brunner R, Zauner C, Schellongowski P, Heinz G, Funk G, Trauner M, Schneeweiss B, Fuhrmann V
ANN INTENSIVE CARE. 2018;8(1):48.

Long-term neurological outcomes in patients aged over 90 years who are admitted to the intensive care unit following cardiac arrest
Roedl K, Jarczak D, Becker S, Fuhrmann V, Kluge S, Müller J
RESUSCITATION. 2018;132(11):6-12.

Reanimation bei über 90-jährigen Patienten: Macht das wirklich Sinn?
Roedl K, Kluge S, Müller J
Intensiv News. 2018;22(6):13-18.

Akutes Leberversagen
Rutter K, Horvatits T, Drolz A, Roedl K, Siedler S, Kluge S, Fuhrmann V
MED KLIN-INTENSIVMED. 2018;113(3):174-183.

Der besondere Fall: Geglückter Rettungsversuch bei Herzkreislaufstillstand
Söffker G, Lubos E, Issleib M, Ulrich M, Roedl K, Zöllner C, Reichenspurner H, Blankenberg S, Kluge S
Hamb Ärztebl. 2018;2018(6/7):34-35.

Serum bile acids as marker for acute decompensation and ACLF in patients with non-cholestatic cirrhosis
Horvatits T, Drolz A, Roedl K, Rutter K, Ferlitsch A, Fauler G, Trauner M, Fuhrmann V
LIVER INT. 2017;37(2):224-231.

Serum bile acids in patients with hepatopulmonary syndrome
Horvatits T, Drolz A, Rutter K, Roedl K, Fauler G, Müller C, Kluge S, Trauner M, Schenk P, Fuhrmann V
Z GASTROENTEROL. 2017;55(4):361-367.

Circulating bile acids predict outcome in critically ill patients
Horvatits T, Drolz A, Rutter K, Roedl K, Langouche L, Van den Berghe G, Fauler G, Meyer B, Hülsmann M, Heinz G, Trauner M, Fuhrmann V
ANN INTENSIVE CARE. 2017;7:48.

Organinteraktion Leber und Niere
Roedl K, Jarczak D, Fuhrmann V
DEUT MED WOCHENSCHR. 2017;142(18):1365-1372.

Outcome of in- and out-of-hospital cardiac arrest survivors with liver cirrhosis
Roedl K, Wallmüller C, Drolz A, Horvatits T, Rutter K, Spiel A, Ortbauer J, Stratil P, Hubner P, Weiser C, Motaabbed J, Jarczak D, Herkner H, Sterz F, Fuhrmann V
ANN INTENSIVE CARE. 2017;7(1):103.

Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implications
Staufer K, Roedl K, Kivaranovic D, Drolz A, Horvatits T, Rasoul-Rockenschaub S, Zauner C, Trauner M, Fuhrmann V
LIVER INT. 2017;37(6):843-850.

Intrapulmonary Human Cytomegalovirus Replication in Lung Transplant Recipients Is Associated With a Rise of CCL-18 and CCL-20 Chemokine Levels
Weseslindtner L, Görzer I, Roedl K, Küng E, Jaksch P, Klepetko W, Puchhammer-Stöckl E
TRANSPLANTATION. 2017;101(1):197-203.

Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit
Drolz A, Horvatits T, Roedl K, Rutter K, Staufer K, Haider D, Zauner C, Heinz G, Schellongowski P, Kluge S, Trauner M, Fuhrmann V
ANN INTENSIVE CARE. 2016;6(1):61.

Coagulation parameters and major bleeding in critically ill patients with cirrhosis
Drolz A, Horvatits T, Roedl K, Rutter K, Staufer K, Kneidinger N, Holzinger U, Zauner C, Schellongowski P, Heinz G, Perkmann T, Kluge S, Trauner M, Fuhrmann V
HEPATOLOGY. 2016;64(2):556-68.

Postpylorische Ernährung beim kritisch Kranken - wann und wie?
Drolz A, Horvatits T, Rutter K, Roedl K, Fuhrmann V
2016. DIVI Jahrbuch 2015/2016. Kluge S, Markewitz A, Jorch G, Putensen C, Quintel M, Sybrecht G (eds.). 1. ed. Berlin: 313-318.

Extrakorporale Therapien bei Lebererkrankungen
Fuhrmann V, Drolz A, Rutter K, Roedl K, Wüstenberg R, Horvatits T
2016. DIVI Jahrbuch 2015/2016. Kluge S, Markewitz A, Jorch G, Putensen C, Quintel M, Sybrecht G (eds.). 1. ed. Berlin: 181-187.

Gut Ding braucht Weile: Plasmaaustausch verbessert das Überleben bei akutem Leberversagen!
Fuhrmann V, Roedl K, Rutter K, Drolz A, Horvatits T, Kluge S, Siedler S
Intensiv News. 2016;20(2):8-10.

Hepatokardiale Wechselwirkungen: Interaktionen zweier Organsysteme
Horvatits T, Drolz A, Rutter K, Roedl K, Kluge S, Fuhrmann V
MED KLIN-INTENSIVMED. 2016;111(5):447-452.

Prediction of major bleeding in cirrhotic ICU patients using the dic score and coagulation parameters
Drolz A, Horvatits T, Roedl K, Rutter K, Kneidinger N, Bopp C, Wüstenberg R, Zauner C, Heinz G, Schellongowski P, Perkmann T, Trauner M, Fuhrmann V
INTENS CARE MED. 2015;3(Suppl 1):A972.

Schockleber beim kritisch Kranken: Gibt es nur symptomatische Therapieoptionen?
Fuhrmann V, Horvatits T, Roedl K, Rutter K, Kluge S, Drolz A
Intensiv News. 2015;19(1):15-17.

Prognostic impact of ICG-PDR in patients with hypoxic hepatitis at the intensive care unit
Horvatits T, Kneidinger N, Drolz A, Roedl K, Rutter K, Kluge S, Fuhrmann V
INTENS CARE MED. 2015;3(Suppl 1):A974.

Prognostic impact of ICG-PDR in patients with hypoxic hepatitis
Horvatits T, Kneidinger N, Drolz A, Roedl K, Rutter K, Kluge S, Trauner M, Fuhrmann V
ANN INTENSIVE CARE. 2015;5(1):47.

Statin therapy is associated with reduced incidence of hypoxic hepatitis in critically ill patients
Drolz A, Horvatits T, Michl B, Roedl K, Schellongowski P, Holzinger U, Zauner C, Heinz G, Madl C, Trauner M, Fuhrmann V
J HEPATOL. 2014;60(6):1187-93.

Schockleber und Cholestase beim kritisch Kranken
Drolz A, Horvatits T, Roedl K, Fuhrmann V
MED KLIN-INTENSIVMED. 2014;109(4):228-34.

vWF, a screening tool for detection of hepatopulmonary syndrome in patients with liver cirrhosis
Horvatits T, Drolz A, Roedl K, Herkner H, Ferlitsch A, Perkmann T, Müller C, Trauner M, Schenk P, Fuhrmann V
J HEPATOL. 2014;61(3):544-549.

High CXCL-16 levels correlate with symptomatic disease in lung transplant recipients with human cytomegalovirus replication in the allograft
Weseslindtner L, Görzer I, Küng E, Roedl K, Jaksch P, Klepetko W, Puchhammer-Stöckl E
AM J TRANSPLANT. 2014;14(10):2406-11.

Clinical impact of arterial ammonia levels in ICU patients with different liver diseases
Drolz A, Jäger B, Wewalka M, Saxa R, Horvatits T, Roedl K, Perkmann T, Zauner C, Kramer L, Ferenci P, Fuhrmann V
INTENS CARE MED. 2013;39(7):1227-37.

Letzte Aktualisierung aus dem FIS: 24.12.2024 - 03:58 Uhr